These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6174255)

  • 61. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
    Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Hepatitis B virus and its role in the development of hepatic carcinoma].
    Horejsí J
    Cas Lek Cesk; 1983 Jan; 122(2):33-5. PubMed ID: 6825138
    [No Abstract]   [Full Text] [Related]  

  • 63. Letter: Hepatitis associated antigen and alpha-feto protein in liver cell carcinoma in Malawi.
    Brown K
    Trans R Soc Trop Med Hyg; 1976; 70(2):164-5. PubMed ID: 60811
    [No Abstract]   [Full Text] [Related]  

  • 64. [Features of hepatitis B virus-related hepatocellular carcinoma].
    Ishikawa T; Ichida T
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():435-9. PubMed ID: 11761988
    [No Abstract]   [Full Text] [Related]  

  • 65. Incidence of hepatitis B-antigenaemia and positive alphafoetoprotein in New Zealand, Western Samoa and Tonga--(a pilot study of Polynesian liver disease).
    Nicholson G
    Ann Acad Med Singap; 1980 Apr; 9(2):201-2. PubMed ID: 6158904
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hepatitis B virus and the prevention of primary hepatocellular carcinoma.
    Blumberg BS; London WT
    N Engl J Med; 1981 Mar; 304(13):782-4. PubMed ID: 6258074
    [No Abstract]   [Full Text] [Related]  

  • 67. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers.
    Yu MW; Hsu FC; Sheen IS; Chu CM; Lin DY; Chen CJ; Liaw YF
    Am J Epidemiol; 1997 Jun; 145(11):1039-47. PubMed ID: 9169913
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hepatitis B virus infection in southern African blacks with hepatocellular cancer.
    Kew MC; Desmyter J; Bradburne AF; Macnab GM
    J Natl Cancer Inst; 1979 Mar; 62(3):517-20. PubMed ID: 84090
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Long-term course in asymptomatic carriers of HBsAg in an area of low prevalence of hepatocarcinoma].
    Jmelnitzky A; Basualdo JA; Castelletto R; Mon JC; Belloni P; Rondina A; García C
    Acta Gastroenterol Latinoam; 1989; 19(1):21-30. PubMed ID: 2481374
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Does delta infection play a part in the pathogenesis of hepatitis B virus related hepatocellular carcinoma?
    Craxì A; Raimondo G; Pagliaro L
    Br Med J (Clin Res Ed); 1984 Aug; 289(6440):322. PubMed ID: 6331566
    [No Abstract]   [Full Text] [Related]  

  • 71. Alpha-fetoprotein in hepatitis superimposed on cirrhosis: a case of concomitant hepatitis B surface antigen and antibody associated with a major but transient increase in the alpha-fetoprotein level.
    Bergmann JF; Lang F; Dechy H; Dorra M
    Am J Gastroenterol; 1985 Oct; 80(10):810-2. PubMed ID: 2412436
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Epidemiology of hepatitis B virus (HBV) infections with particular regard to current routes of transmission and development of cirrhosis and malignancy.
    Norkrans G
    Scand J Infect Dis Suppl; 1990; 69():43-7. PubMed ID: 2175941
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Familial clustering of asymptomatic carriers of Australia antigen and patients with chronic liver disease or primary liver cancer.
    Obayashi A; Okochi K; Mayumi M
    Gastroenterology; 1972 Apr; 62(4):618-25. PubMed ID: 5020874
    [No Abstract]   [Full Text] [Related]  

  • 74. Cirrhosis and liver cancer.
    Arrigoni A; Zago P; Mazzucco D; Andriulli A; Rizzetto M
    Lancet; 1985 Aug; 2(8449):277. PubMed ID: 2862448
    [No Abstract]   [Full Text] [Related]  

  • 75. Primary hepatocellular carcinoma.
    Ebie N; Jensen D; Bines S; Kiel K
    Med Pediatr Oncol; 1986; 14(5):281-7. PubMed ID: 2431256
    [No Abstract]   [Full Text] [Related]  

  • 76. [Management of the chronic carrier of hepatitis B surface antigen (HBsAg)].
    Ramalho F
    Acta Med Port; 1983; 4(11-12):501-8. PubMed ID: 6198872
    [No Abstract]   [Full Text] [Related]  

  • 77. Hepatocellular carcinoma. Identifying and screening populations at increased risk.
    Smith CS; Paauw DS
    Postgrad Med; 1993 Dec; 94(8):71-4. PubMed ID: 7504252
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Titres of Australia (hepatitis-associated) antigen in healthy carriers, leprosy, cirrhosis of the liver and acute hepatitis.
    Kelkar SS; Niphadkar KB; Khare PM
    Indian J Med Res; 1973 May; 61(5):684-8. PubMed ID: 4202881
    [No Abstract]   [Full Text] [Related]  

  • 79. Hepatocellular carcinoma in white South Africans--aetiological considerations.
    Kew MC; Song E; Dusheiko GM
    S Afr Med J; 1984 Dec; 66(22):835-7. PubMed ID: 6095467
    [TBL] [Abstract][Full Text] [Related]  

  • 80. High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors.
    Fasani P; Sangiovanni A; De Fazio C; Borzio M; Bruno S; Ronchi G; Del Ninno E; Colombo M
    Hepatology; 1999 Jun; 29(6):1704-7. PubMed ID: 10347111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.